Cardiol Therapeutics Inc. (CRDL)

Cardiol Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	21.42	30.58	34.93	59.47	83.9
Cash & Short-Term Investments	21.42	30.58	34.93	59.47	83.9
Cash Growth	-29.97%	-12.46%	-41.26%	-29.12%	498.20%
Accounts Receivable	0.06	0.1	0.14	0.21	0.07
Other Receivables	0.17	0.26	0.14	0.27	0.34
Total Trade Receivables	0.23	0.36	0.28	0.48	0.41
Other Current Assets	1.86	0.73	0.94	1.49	2.83
Total Current Assets	23.5	31.67	36.15	61.44	87.14
Net Property, Plant & Equipment	0.12	0.2	0.34	0.3	0.36
Other Intangible Assets	-	-	0.21	0.29	0.38
Total Assets	23.62	31.86	36.7	62.03	87.88
Accounts Payable	3.48	6.98	8.04	9.33	4.86
Current Portion of Leases	0.04	0.03	0.02	0.05	0.04
Other Current Liabilities	2.14	-	0.24	0.42	6.66
Total Current Liabilities	5.66	7.01	8.3	9.8	11.57
Long-Term Leases	0.09	0.13	0.16	0.02	0.07
Total Long-Term Liabilities	0.09	0.13	0.16	0.02	0.07
Total Liabilities	5.74	7.14	8.45	9.83	11.64
Common Stock	201.87	179.34	148.52	147.55	142.92
Additional Paid-in Capital	29.08	24.65	22.3	19.1	16.84
Retained Earnings	-213.07	-179.25	-142.58	-114.45	-83.52
Shareholders' Equity	17.88	24.73	28.25	52.2	76.24
Total Liabilities & Equity	23.62	31.86	36.7	62.03	87.88
Total Debt	0.13	0.16	0.17	0.07	0.12
Net Cash (Debt)	21.29	30.42	34.76	59.4	83.78
Net Cash Growth	-30.01%	-12.47%	-41.48%	-29.10%	504.11%
Net Cash Per Share	0.24	0.42	0.54	0.95	1.94
Book Value	17.88	24.73	28.25	52.2	76.24
Book Value Per Share	0.21	0.35	0.44	0.84	1.76
Tangible Book Value	17.88	24.73	28.04	51.91	75.86
Tangible Book Value Per Share	0.21	0.35	0.43	0.83	1.76

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q